Cargando…
Anti-angiogenic effects of crenolanib are mediated by mitotic modulation independently of PDGFR expression
BACKGROUND: Crenolanib is a tyrosine kinase inhibitor targeting PDGFR-α, PDGFR-β and Fms related tyrosine kinase-3 (FLT3) that is currently evaluated in several clinical trials. Although platelet-derived growth factor receptor (PDGFR) signalling pathway is believed to play an important role in angio...
Autores principales: | Berndsen, Robert H., Castrogiovanni, Cédric, Weiss, Andrea, Rausch, Magdalena, Dallinga, Marchien G., Miljkovic-Licina, Marijana, Klaassen, Ingeborg, Meraldi, Patrick, van Beijnum, Judy R., Nowak-Sliwinska, Patrycja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738084/ https://www.ncbi.nlm.nih.gov/pubmed/31235865 http://dx.doi.org/10.1038/s41416-019-0498-2 |
Ejemplares similares
-
Forcing dividing cancer cells to die; low‐dose drug combinations to prevent spindle pole clustering
por: Ducrey, Eloise, et al.
Publicado: (2021) -
Erratum: Berndsen, R.H., et al. Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib, Cancers 2019, 11, 1878
por: Berndsen, Robert H., et al.
Publicado: (2020) -
Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib
por: Berndsen, Robert H., et al.
Publicado: (2019) -
Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering
por: Weiss, Andrea, et al.
Publicado: (2019) -
Crenolanib, a PDGFR inhibitor, suppresses lung cancer cell proliferation and inhibits tumor growth in vivo
por: Wang, Ping, et al.
Publicado: (2014)